Synergistic Activity of the MCL-1 Inhibitor S63845 with Midostaurin in Preclinical Human Models of FLT3-ITD Mutated Acute Myeloid Leukemia (AML)

著录项

• 来源
  《Clinical lymphoma, myeloma & leukemia》 |2019年第1期|共2页
• 作者

  Skwarska Anna; Panis Paul; Zhang Qi; Herbrich Shelley; Kurvilla Vinitha M.; Baran Natalia; Halilovic Ensar; Ruvolo Peter; Ruvolo Vivian; Morris Erick; Wei Andrew; Moujalled Donia; Derreal Alix; Banquet Sebastien; Andreeff Michael; Konopleva Marina;

  展开▼
• 作者单位

  Univ Oxford Dept Oncol Oxford England;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Novartis Inst Biomed Res Cambridge MA USA;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Novartis Inst Biomed Res Cambridge MA USA;

  Alfred Hosp Melbourne Vic Australia;

  Alfred Hosp Melbourne Vic Australia;

  Inst Rech Int Servier Oncol R&

  D Unit Suresnes France;

  Inst Rech Int Servier Oncol R&

  D Unit Suresnes France;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词

  acute myeloid leukemia; FLT3-ITD; Mcl-1; midostaurin; BH3-mimetic drugs; AML;

  机译：急性髓性白血病;FLT3-ITD;MCL-1;中豚;BH3模仿药物;AML;